Showing recent highlights
What's New
PubMed · December 31, 2026
Researchers looked at a group of studies and found that low sodium levels in the blood — a condition called hyponatremia, where the body doesn't have enough of this important mineral — appear to be surprisingly common in people with COPD (a serious lung disease that makes breathing difficult). About 1 in 5 people with a sudden COPD flare-up may have this issue, which is worth paying attention to because low sodium can affect how the body functions overall. Interestingly, most of the studies didn't find a clear link between low sodium and a higher risk of death from a COPD flare-up, but scientists say the results varied too much between studies to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers in China tested whether a low dose of an older medicine called theophylline — which can reduce inflammation in the airways — might help people with mild to moderate COPD, a lung disease that makes breathing harder over time. They found a small improvement in lung function (how much air people could blow out), but the medicine did not reduce the number of times patients had flare-ups, which are sudden worsening spells that can be dangerous. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
A study found that in ex-smokers — both those with COPD and those considered at risk for it — mucus plugs in the airways kept forming and shifting over time, even when overall mucus levels stayed roughly the same. More importantly, these participants also showed a gradual decline in how far they could walk and how well air moved through their lungs, suggesting that mucus buildup may be quietly contributing to worsening lung health even in earlier or milder stages of the disease. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that people with COPD — a lung condition that makes it hard to breathe — face a mix of real-world challenges when trying to manage their condition day to day. Things like rushed doctor appointments, feelings of shame or emotional distress, and not getting enough clear information from healthcare professionals made it harder for people to stick to their treatment plans, while having strong support from family and friends and feeling genuinely heard by their care team made a big difference. Understanding what gets in the way — and what helps — could lead to better, more personalized support for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that certain biologic medications — injectable drugs that target specific parts of the immune system to reduce inflammation — may help people with moderate-to-severe COPD (a serious lung disease that makes breathing difficult) have fewer flare-ups, which are episodes when symptoms suddenly get much worse. Specifically, they found that for every 12 to 17 people treated with a biologic called dupilumab, roughly one person avoided a flare-up they otherwise would have had — and when looking at the total number of flare-ups prevented, the benefit appeared even stronger. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that digital tools designed to help people with COPD (a lung disease that makes breathing difficult) manage their condition on their own — things like apps, online programs, or remote monitoring — were linked to improvements in physical activity, quality of life, lung function, medication adherence, and mental health challenges like anxiety and depression. This matters because COPD can be isolating and hard to manage day-to-day, and digital tools could make support more accessible to more people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that applying elastic tape — a stretchy, supportive tape placed on the chest — alongside a standard breathing and exercise program helped men with moderate-to-severe COPD walk longer, breathe more comfortably, and feel less anxious or depressed compared to those who did the program without the tape. COPD is a lung disease that makes it hard to breathe, and finding ways to get more out of exercise programs matters a lot for people living with it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that people with COPD (a chronic lung disease that makes breathing difficult) face a higher risk of serious heart problems like heart attacks or strokes in the weeks right after a severe flare-up of their condition — especially if that flare-up was bad enough to require a hospital stay. The risk appeared to be highest in the first 30 days after the flare-up, suggesting that this window of time may be especially important to watch closely. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that delivering a protein called interferon-beta — which the body naturally uses to fight viruses — directly into the nose or lungs (through a spray or inhaler) may help the body better defend itself against respiratory viral infections. This is particularly interesting for people with asthma, because their airways often have a weaker natural antiviral response, which can make viral infections like colds or flu trigger more serious flare-ups. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that complementary therapies — things like yoga, tai chi, music therapy, and water-based exercise — may help people with COPD (a lung condition that makes breathing difficult) feel better both physically and emotionally, with improvements in how far they could walk, how breathless they felt, and their levels of anxiety and depression. Some of these approaches even showed small advantages over standard pulmonary rehabilitation, which is the usual structured exercise and education program doctors recommend for COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a structured exercise and breathing program called pulmonary rehabilitation may help reduce 'lung hyperinflation' in people with COPD — that's when the lungs trap too much air and don't fully empty, making it harder to breathe. Across multiple studies, people who went through pulmonary rehabilitation tended to breathe more efficiently, with less air getting stuck in their lungs after each breath. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that people with COPD (a lung condition that makes breathing difficult) are more likely to exercise regularly when they feel motivated, have a higher education level, better lung function, and strong support from people around them — while those with more severe symptoms tend to exercise less. This matters because staying active is a key part of managing COPD, yet many people with the condition struggle to exercise consistently, and understanding what helps or gets in the way could lead to better support programs. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that pulmonary rehabilitation — a structured exercise and education program designed to help people breathe better and stay active — can be delivered successfully through private physiotherapy and exercise clinics, not just large hospital centers. In a study of 52 people with chronic lung disease like COPD, 75% of those assigned to the program completed it, and participants showed meaningful improvements in their ability to exercise and their overall quality of life. This matters because one of the biggest challenges for people with COPD is simply being able to access these programs, and this research suggests neighborhood-based private clinics could be a practical alternative. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a drug called mepolizumab may help people with a specific type of COPD (a lung disease that makes it hard to breathe) — particularly those whose condition is driven by high levels of certain immune cells called eosinophils, which cause inflammation in the airways. Across four studies involving nearly 2,000 patients, mepolizumab reduced the rate of serious breathing flare-ups by about 20% and appeared to delay how long it took for a flare-up to occur, all without increasing the risk of side effects. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether mepolizumab injections might help reduce how often the patient has flare-ups if the patient has COPD with high eosinophil counts.
What's New
PubMed · November 1, 2026
Researchers found that two types of exercise programs — one using short bursts of intense effort (called high-intensity interval training) and one using steady, moderate effort (called moderate-intensity continuous training) — both help people with COPD, a lung disease that makes breathing difficult. Neither approach was clearly better overall: the steady, moderate exercise showed a slight edge in peak oxygen uptake (how efficiently the body uses oxygen during exercise), while the burst-style training led to modest improvements in how far people could walk in six minutes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 17, 2026
Researchers found that breathing in outdoor ozone — a type of air pollution formed when sunlight reacts with chemicals in the air — is linked to real harm to the lungs, more asthma flare-ups, and more emergency room visits, even when ozone levels are below the limits currently set by the EPA. People with asthma, children, and older adults appear to be hit the hardest, and the review even found that high ozone days are connected to kids missing more school due to breathing problems. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · October 12, 2026
A study found that people with COPD — a lung disease that makes breathing difficult — who did a structured 12-week exercise program three times a week saw improvements in how well air moved through the smaller airways deep in their lungs. The program combined moderate-intensity aerobic activity, like walking or cycling to get the heart rate up, with muscle-strengthening exercises, and was supervised and tailored to each person. Researchers found these breathing improvements showed up on a sensitive lung test called impulse oscillometry, which can detect changes that standard breathing tests sometimes miss.
What's New
PubMed · October 10, 2026
Researchers found that people with COPD who use a breathing support machine at home (called noninvasive ventilation, or NIV — a mask-based device that helps open the airways during sleep or rest) had fewer sleep problems and felt better managing their symptoms after going through an online education program compared to those who didn't. The improvements in sleep quality took about 8 weeks to show up clearly, suggesting that patient education may take some time to make a real difference. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that adding metoprolol — a type of heart medication called a beta-blocker — to standard care for people with COPD (a lung condition that makes breathing difficult) did not significantly reduce the chances of a flare-up, serious heart problems like heart attacks or strokes, or death compared to standard care alone. In fact, people taking metoprolol had slightly more side effects than those who didn't take it. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that taking probiotic supplements — the beneficial bacteria found in products like yogurt — may help improve lung function and reduce inflammation in people with COPD, a lung disease that makes it hard to breathe. The idea behind this is something called the gut-lung connection, meaning the health of your digestive system can actually influence how well your lungs work. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that a new inhaled medication called TQC3721 — designed to both open up the airways and reduce inflammation in the lungs — showed promising results in people with moderate to severe COPD (a lung disease that makes it hard to breathe). In early testing, people who took it experienced noticeable improvements in how much air they could breathe out within about two hours of taking a dose, and the effect lasted around 12 hours, suggesting it could eventually be taken twice a day. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that a special type of lung MRI scan — one that tracks airflow and blood circulation in detail — was able to detect improvements in the lungs of people with moderate-to-severe COPD after they took a common inhaled bronchodilator (a medication that helps open the airways). The scans showed that after just one dose, areas of the lung that weren't getting enough airflow or blood flow started to improve, suggesting this MRI technique may be a sensitive new way to measure how well a treatment is working. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people with asthma or COPD (a lung disease that makes breathing difficult) who came from lower-income backgrounds got significantly better care when a trained health coach worked alongside a lung specialist to support them — they received about 60% more guideline-based care compared to patients who got standard care alone. The health coach gathered information from the patient and shared it with a lung specialist, who then gave recommendations to the patient's primary care doctor, and the coach helped make sure those recommendations were actually followed. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that mind-body exercises — like Pilates, Yoga, Tai Chi, and Qigong — can meaningfully help people with COPD (a lung condition that makes breathing difficult). Pilates combined with a breathing-focused rehab program showed the biggest improvements in physical endurance and lung function, while Tai Chi was especially helpful for easing the feeling of breathlessness and improving overall quality of life. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that people with COPD who joined a 12-week online group singing program showed some signs of feeling better mentally, particularly those who attended at least 8 of the sessions — though the overall results weren't strong enough to be considered definitive. Researchers found the online singing groups were safe and practical to run, with no harmful effects reported for any participants. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that starting a home-based exercise and breathing program within a week of leaving the hospital may help people with COPD rebuild their strength and activity levels — something that's especially hard to do after a hospital stay, when the body can quickly weaken. The study looked at whether adding high-flow nasal oxygen (a device that delivers a steady stream of warm, humidified oxygen through the nose during exercise) made the program more effective, but both groups — those who used the oxygen device and those who didn't — showed similar improvements in physical fitness. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 21, 2026
A study found that for people with chronic lung disease whose oxygen levels drop during exercise, using a small portable oxygen device while walking didn't help them walk noticeably farther compared to breathing regular air — but it did make breathing feel easier and less uncomfortable during the effort. Interestingly, patients were almost evenly split on which they preferred, and a small number of people did walk meaningfully farther with the oxygen, suggesting it may help certain individuals more than others. This is early research and hasn't yet changed treatment guidelines.
Medications
NEJM · September 8, 2026
A study examined tozorakimab, a newer medication being tested in people with COPD (a lung disease that makes breathing difficult over time). Researchers found it was being looked at for its potential to reduce exacerbations — which are sudden flare-ups where breathing gets significantly worse, often landing people in the hospital. This appears to be a new treatment option still being evaluated, rather than an established recommendation or a safety warning.
What's New
PubMed · September 3, 2026
Researchers found that a blood-filtering technique called ECCO₂R — which removes carbon dioxide from the blood outside the body to help the lungs rest — may help people with severe COPD get off a breathing machine (ventilator) much sooner than those receiving standard care, roughly 7 days compared to 16 days on average. Spending less time on a ventilator matters because it lowers the risk of serious complications like lung infections, which showed up in none of the patients using the technique versus several in the standard care group. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that a structured self-management program — where people with chronic conditions like type 2 diabetes learn skills to manage their health day-to-day — led to lasting improvements in sleep, pain, fatigue, and mood, even six months after the program ended, across many different countries. For someone with type 2 diabetes, this matters because managing a long-term condition involves a lot more than just medication — things like energy levels, sleep, and emotional well-being all affect how well someone can stay on top of their health. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.